» Articles » PMID: 29430158

Delayed Presentation of Turner Syndrome: Challenge to Optimal Management

Overview
Date 2018 Feb 13
PMID 29430158
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Turner syndrome (TS) is a chromosomal disorder associated with dysmorphic features and comorbidities, with recent trends focusing on early diagnosis for adequate management.

Aim: The aim is to study the age and mode of presentation of TS, associated comorbidities and look for any correlation with the genotype.

Material And Methods: This was a retrospective analysis of girls with TS attending the endocrinology clinic of a tertiary care center. Their age, mode of presentation, and clinical features were noted. All participants underwent ear examination, echocardiography, and ultrasonography of the abdomen. Laboratory investigations included serum T4, thyroid-stimulating hormone, thyroid peroxidase antibodies, follicle-stimulating hormone, fasting, and 2-h plasma glucose after 75 g glucose load and a karyotype. Simple descriptive statistical methods were used.

Results: Seventeen cases of TS were seen with a median age of presentation of 18 years (range 14-42 years). Primary amenorrhea was the most common reason for seeking medical attention (76.4%) followed by short stature and diabetes mellitus (11.8% each). The mean height at presentation was 137.5 ± 5.4 cm. Monosomy of X chromosome (45,X) was the most common karyotype obtained in 58.8% of the patients, followed by 45,X/46, XX in 17.6%, 45,X/46X,i(X)(q10) in 11.8%, and 45,X/47,XXX and 46X,delXp11.2 in 5.9% patients each. Bicuspid aortic valve was seen in two patients having a 45,X/46,XX karyotype.

Conclusion: Primary amenorrhea is the most common presenting feature in girls with TS leading to a delayed age of presentation. Short stature and dysmorphic features are often overlooked in infancy and childhood due to socioeconomic factors. This late age of presentation is a cause of concern as early detection and management is important for height outcomes, bone health, and psychosocial support. Assessment of comorbidities becomes important in this setting.

Citing Articles

Prevalence and Predictors of Prediabetes in Adolescents and Young Adults with Turner Syndrome: A Cross-Sectional Study from Eastern India.

Mondal S, Gargari P, Bose C, Chowdhury S, Mukhopadhyay S Indian J Endocrinol Metab. 2023; 27(4):335-345.

PMID: 37867982 PMC: 10586561. DOI: 10.4103/ijem.ijem_22_23.


Delayed pubarche.

Baldo F, Barbi E, Tornese G Ital J Pediatr. 2021; 47(1):180.

PMID: 34488834 PMC: 8422600. DOI: 10.1186/s13052-021-01134-0.


Ovarian reserve evaluation in a woman with 45,X/47,XXX mosaicism: A case report and a review of literature.

Tang R, Lin L, Guo Z, Hou H, Yu Q Mol Genet Genomic Med. 2019; 7(7):e00732.

PMID: 31070017 PMC: 6625135. DOI: 10.1002/mgg3.732.

References
1.
Bondy C, Bakalov V, Cheng C, Olivieri L, Rosing D, Arai A . Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome. J Med Genet. 2013; 50(10):662-5. PMC: 3786649. DOI: 10.1136/jmedgenet-2013-101720. View

2.
Lee M, Conway G . Turner's syndrome: challenges of late diagnosis. Lancet Diabetes Endocrinol. 2014; 2(4):333-338. DOI: 10.1016/S2213-8587(13)70153-0. View

3.
Zhong Q, Layman L . Genetic considerations in the patient with Turner syndrome--45,X with or without mosaicism. Fertil Steril. 2012; 98(4):775-9. PMC: 3573687. DOI: 10.1016/j.fertnstert.2012.08.021. View

4.
Sybert V . Phenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome. J Med Genet. 2002; 39(3):217-20. PMC: 1735059. DOI: 10.1136/jmg.39.3.217. View

5.
Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon J, Craen M . Trends in age at diagnosis of Turner syndrome. Arch Dis Child. 2005; 90(3):267-8. PMC: 1720288. DOI: 10.1136/adc.2004.049817. View